These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 17573985)
1. Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions. Opmeer BC; Heydendael VM; deBorgie CA; Spuls PI; Bossuyt PM; Bos JD; de Rie MA J Clin Epidemiol; 2007 Jul; 60(7):696-703. PubMed ID: 17573985 [TBL] [Abstract][Full Text] [Related]
2. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Naldi L; Griffiths CE Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088 [TBL] [Abstract][Full Text] [Related]
3. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421 [TBL] [Abstract][Full Text] [Related]
4. Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis. Seston EM; Ashcroft DM; Griffiths CE Arch Dermatol; 2007 Sep; 143(9):1175-9. PubMed ID: 17875880 [TBL] [Abstract][Full Text] [Related]
5. Comparative tolerability of systemic treatments for plaque-type psoriasis. McClure SL; Valentine J; Gordon KB Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213 [TBL] [Abstract][Full Text] [Related]
6. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis']. Spuls PI; Tuut MK; van Everdingen JJ; de Rie MA; Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2121-5. PubMed ID: 15553355 [TBL] [Abstract][Full Text] [Related]
7. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists. Katz HI J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188 [TBL] [Abstract][Full Text] [Related]
8. Acitretin for the treatment of psoriasis: an assessment of national trends. Ghasri P; Yentzer BA; Dabade TS; Feldman SR J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508 [TBL] [Abstract][Full Text] [Related]
9. Adverse events from systemic therapies for psoriasis are common in clinical practice. Pearce DJ; Higgins KB; Stealey KH; Balkrishnan R; Crane MM; Camacho F; Fleischer AB; Feldman SR J Dermatolog Treat; 2006; 17(5):288-93. PubMed ID: 17092859 [TBL] [Abstract][Full Text] [Related]
10. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan. Feldman SR; Evans C; Russell MW J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Carlin CS; Callis KP; Krueger GG Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089 [TBL] [Abstract][Full Text] [Related]
12. Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine. Opmeer BC; Heydendael VM; De Borgie CA; Spuls PI; Bossuyt PM; Bos JD; De Rie MA Arch Dermatol; 2004 Jun; 140(6):685-90. PubMed ID: 15210458 [TBL] [Abstract][Full Text] [Related]
13. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis. Yelverton CB; Yentzer BA; Clark A; Pearce DJ; Balkrishnan R; Camacho FT; Boles A; Fleischer AB; Feldman SR Arch Dermatol; 2008 Sep; 144(9):1224-5. PubMed ID: 18794474 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial. Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660 [TBL] [Abstract][Full Text] [Related]
15. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Gisondi P; Del Giglio M; Cotena C; Girolomoni G Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy to treat moderate to severe psoriasis. Lebwohl M; Menter A; Koo J; Feldman SR J Am Acad Dermatol; 2004 Mar; 50(3):416-30. PubMed ID: 14988684 [TBL] [Abstract][Full Text] [Related]
18. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis. Short MW; Vaughan TK Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760 [TBL] [Abstract][Full Text] [Related]
19. Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases. Philipp S; Wilsmann-Theis D; Weyergraf A; Rotterdam S; Frambach Y; Gerdes S; Mössner R J Dtsch Dermatol Ges; 2012 Nov; 10(11):821-37. PubMed ID: 22934607 [TBL] [Abstract][Full Text] [Related]
20. A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis. Krueger GG; Gottlieb AB; Sterry W; Korman N; Van De Kerkhof P J Dermatolog Treat; 2008; 19(3):146-55. PubMed ID: 18569270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]